TAIPEI, Nov. 8, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today preclinical data in the European Heart Journal, demonstrating that activation of Aldehyde Dehydrogenase 2 (ALDH2) with Foresee's oral ALDH2 activator AD-9308, significantly ameliorates heart failure via the modulation of the... read full story
" Kiyuna L, Candido D, Bechara L, Jesus I, Ramalho L, Krum B, et al. 4-hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification. European Heart Journal 2023; doi:10.1093/eurheartj/ehad662"